The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

A separate analysis of the real-world trial found that those who switched from daily antiretroviral treatment to Cabenuva had fewer concerns about treatment.

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

The FDA approval of lenacapavir as a form of preexposure prophylaxis (PrEP) is a major step for HIV prevention, but its ...

Experts, such as Lloyd Mulenga, M.Sc., M.B., Ch.B., Ph.D., discuss long-acting injectable HIV PrEP's potential in Zambia, ...

A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...